Company Profile LogoSparrow Pharmaceuticals

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Edit IconSuggest an Edit
Therapeutics
Pharmaceutical
Biotechnology
Biopharma

    Unlock insights on Sparrow Pharmaceuticals and 2M+ companies now!

    About Sparrow Pharmaceuticals

    Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess. It was founded to spare patients the ravages of steroids. Leveraging underappreciated scientific insights into corticosteroid biology, the company is working to provide better treatment options for serious disorders of hypercortisolism and to revolutionize the treatment of autoimmune and inflammatory conditions. Its lead product, SPI-62, is an oral, small molecule,

    Repeat Founder
    Top 100 in Biopharma in United States
    Company Highlights
    Year Founded

    2013

    icon-altEmployees

    14

    Location (HQ)

    USA

    Since Last Funding

    4 months

    Monthly Website Visitors

    9.8K

    icon-altTotal Investment Amt

    $61M

    Last Funding Round

    Series Unknown

    icon-altMoM Headcount Growth

    7.63%

    icon-altYoY Headcount Growth

    39.6%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Pharmaceutical

    Biotechnology

    Pharmaceuticals

    Therapeutics

    Pharmaceutical Manufacturing

    Biopharma